Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -2299.40% is 13% above its 1-year average of -2653.73%, around the middle of its 1-year range (-3107.48%–-1746.23%).
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2025 (2025-12-31): -3107.48%.
EBITDA MARGIN
-2299.40%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$29.74M
EBITDA Margin
-17954.61%
TTM Avg
-17954.61%
3Y Avg
-17954.61%
5Y Avg
-17954.61%
Market Cap
$30.19M
EBITDA Margin
-3.61%
TTM Avg
-0.43%
3Y Avg
-7.34%
5Y Avg
-19.38%
Market Cap
$28.47M
EBITDA Margin
-2671.72%
TTM Avg
-3785.12%
3Y Avg
-14400.08%
5Y Avg
-14400.08%
Market Cap
$28.31M
EBITDA Margin
-706.55%
TTM Avg
-1095.73%
3Y Avg
-881.72%
5Y Avg
-688.00%
Market Cap
$30.44M
EBITDA Margin
-76.51%
TTM Avg
-510.64%
3Y Avg
-659.38%
5Y Avg
-619.37%
Market Cap
$28.10M
EBITDA Margin
-989.17%
TTM Avg
-572.43%
3Y Avg
-292.90%
5Y Avg
-228.52%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $29.37M | -2299.40% | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $30.19M | -3.61% | -0.43% | -7.34% | -19.38% |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | -2671.72% | -3785.12% | -14400.08% | -14400.08% |
| OneMedNet Corporation (ONMD)vs › | $28.31M | -706.55% | -1095.73% | -881.72% | -688.00% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.44M | -76.51% | -510.64% | -659.38% | -619.37% |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | -989.17% | -572.43% | -292.90% | -228.52% |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | -11386.31% | -11386.31% | -11386.31% | -3888.42% |
Gross Margin
80.0%
EBITDA Margin
-2299.4%
Operating Margin
-2414.0%
Net Margin
-9572.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | -3107.48% |
| 2025-09-30 | -3107.48% |
| 2025-06-30 | -1746.23% |
